Medicis Pharmaceutical Corp. (NASDAQ:MDRXA) said AlliedCapital Advisers Inc. of Washington, D.C., has agreed inprincipal to provide Medicis with $8 million in long-termfinancing, involving senior and subordinated debt. New York-based Medicis will issue to Allied warrants for an undisclosednumber of shares of Medicis class A common stock. The moneywill be used in part for the acquisition of the Esoterica skin-care product line. The loan is subject to due diligence by Alliedand approval by the boards of both companies.
(c) 1997 American Health Consultants. All rights reserved.